Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 24;9(24):4659-4664.
doi: 10.7150/jca.26674. eCollection 2018.

Fertility Sparing Management in Non-Epithelial Ovarian Cancer. Which Patients, What Procedure and What Outcome?

Affiliations
Review

Fertility Sparing Management in Non-Epithelial Ovarian Cancer. Which Patients, What Procedure and What Outcome?

Nikolaos Thomakos et al. J Cancer. .

Abstract

Non epithelial ovarian tumors represent a small group of rare gynecological cancers but they have a high incidence in young childbearing women. The recent years fertility preservation surgeries have become a common practice in specific ovarian malignancies when the patients wish to maintain their fertility. Specific types of non-epithelial ovarian tumors can be managed with fertility sparing operations with a similar outcome to more radical intervention but due to the rarity of these tumors the extent of the operation remains in some cases controversial. Moreover, the reproductive outcome of the women that had these conservative operations seems to be very promising. In our review we try to summarize the data regarding the fertility sparing management of all types of non-epithelial ovarian cancers and what procedure should be performed in each case. Finally we have accumulated the data concerning the reproductive outcome of patients that had undergone this type of surgery.

Keywords: fertility preservation; non-epithelial ovarian cancer; reproductive outcome.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

References

    1. Monk BJ, Chan JK. American Society of Clinical Oncology 2010 Annual Meeting update: summary of selected gynecologic cancer abstracts. Gynecologic oncology. 2010;118:216–9. - PubMed
    1. Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY. et al. Incidence and survival rates for female malignant germ cell tumors. Obstetrics and gynecology. 2006;107:1075–85. doi:10.1097/01.AOG.0000216004.22588.ce. - PubMed
    1. Mitchell PL, Al-Nasiri N, A'Hern R, Fisher C, Horwich A, Pinkerton CR. et al. Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer. 1999;85:2232–44. - PubMed
    1. Talerman A. Germ cell tumors of the ovary. Current opinion in obstetrics & gynecology. 1997;9:44–7. - PubMed
    1. dos Santos Silva I, Swerdlow AJ. Ovarian germ cell malignancies in England: epidemiological parallels with testicular cancer. British journal of cancer. 1991;63:814–8. - PMC - PubMed